The method developer's guide to oligonucleotide design.

IF 3.8 3区 生物学 Q1 BIOCHEMICAL RESEARCH METHODS Expert Review of Proteomics Pub Date : 2024-01-01 Epub Date: 2024-02-16 DOI:10.1080/14789450.2024.2318565
Leonie Wenson, Mattias Leino, Malin Jarvius, Johan Heldin, Björn Koos, Ola Söderberg
{"title":"The method developer's guide to oligonucleotide design.","authors":"Leonie Wenson, Mattias Leino, Malin Jarvius, Johan Heldin, Björn Koos, Ola Söderberg","doi":"10.1080/14789450.2024.2318565","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Development of new methods is essential to make great leaps in science, opening up new avenues for research, but the process behind method development is seldom described.</p><p><strong>Areas covered: </strong>Over the last twenty years we have been developing several new methods, such as in situ PLA, proxHCR, and MolBoolean, using oligonucleotide-conjugated antibodies to visualize protein-protein interactions. Herein, we describe the rationale behind the oligonucleotide systems of these methods. The main objective of this paper is to provide researchers with a description on how we thought when we designed those methods. We also describe in detail how the methods work and how one should interpret results.</p><p><strong>Expert opinion: </strong>Understanding how the methods work is important in selecting an appropriate method for your experiments. We also hope that this paper may be an inspiration for young researchers to enter the field of method development. Seeing a problem is a motivation to develop a solution.</p>","PeriodicalId":50463,"journal":{"name":"Expert Review of Proteomics","volume":" ","pages":"65-80"},"PeriodicalIF":3.8000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Proteomics","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1080/14789450.2024.2318565","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/16 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Development of new methods is essential to make great leaps in science, opening up new avenues for research, but the process behind method development is seldom described.

Areas covered: Over the last twenty years we have been developing several new methods, such as in situ PLA, proxHCR, and MolBoolean, using oligonucleotide-conjugated antibodies to visualize protein-protein interactions. Herein, we describe the rationale behind the oligonucleotide systems of these methods. The main objective of this paper is to provide researchers with a description on how we thought when we designed those methods. We also describe in detail how the methods work and how one should interpret results.

Expert opinion: Understanding how the methods work is important in selecting an appropriate method for your experiments. We also hope that this paper may be an inspiration for young researchers to enter the field of method development. Seeing a problem is a motivation to develop a solution.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
方法开发人员的寡核苷酸设计指南。
简介:新方法的开发对于实现科学的重大飞跃、开辟新的研究途径至关重要,但方法开发背后的过程却很少被描述:在过去的二十年中,我们一直在开发几种新方法,如原位聚合酶链反应(in situ PLA)、proxHCR 和 MolBoolean,使用寡核苷酸结合的抗体来观察蛋白质与蛋白质之间的相互作用。在此,我们将介绍这些方法的寡核苷酸系统的原理。本文的主要目的是向研究人员介绍我们在设计这些方法时是如何思考的。我们还详细介绍了这些方法的工作原理以及如何解释结果:专家意见:了解这些方法的工作原理对于为您的实验选择合适的方法非常重要。我们也希望这篇论文能对年轻研究人员进入方法开发领域有所启发。看到问题是开发解决方案的动力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Expert Review of Proteomics
Expert Review of Proteomics 生物-生化研究方法
CiteScore
7.60
自引率
0.00%
发文量
20
审稿时长
6-12 weeks
期刊介绍: Expert Review of Proteomics (ISSN 1478-9450) seeks to collect together technologies, methods and discoveries from the field of proteomics to advance scientific understanding of the many varied roles protein expression plays in human health and disease. The journal coverage includes, but is not limited to, overviews of specific technological advances in the development of protein arrays, interaction maps, data archives and biological assays, performance of new technologies and prospects for future drug discovery. The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections: Expert Opinion - a personal view on the most effective or promising strategies and a clear perspective of future prospects within a realistic timescale Article highlights - an executive summary cutting to the author''s most critical points.
期刊最新文献
Urine proteomics in cardiovascular diseases: advances in biomarker discovery and clinical applications. Identifying therapeutic strategies for triple-negative breast cancer via phosphoproteomics. Proteogenomic profiling of acute myeloid leukemia to identify therapeutic targets. Validating proteomic biomarkers in saliva: distinguishing between health and periodontal diseases. Optimization of glycopeptide enrichment techniques for the identification of clinical biomarkers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1